SNDX vs. VKTX
Compare and contrast key facts about Syndax Pharmaceuticals, Inc. (SNDX) and Viking Therapeutics, Inc. (VKTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNDX or VKTX.
Key characteristics
| SNDX | VKTX | |
|---|---|---|
| YTD Return | -24.99% | 225.63% |
| 1Y Return | 16.96% | 510.27% |
| 3Y Return (Ann) | -3.30% | 115.04% |
| 5Y Return (Ann) | 19.22% | 50.16% |
| Sharpe Ratio | 0.38 | 3.44 |
| Sortino Ratio | 0.82 | 4.87 |
| Omega Ratio | 1.12 | 1.62 |
| Calmar Ratio | 0.38 | 8.67 |
| Martin Ratio | 1.33 | 18.44 |
| Ulcer Index | 14.79% | 28.18% |
| Daily Std Dev | 51.97% | 150.87% |
| Max Drawdown | -78.98% | -90.41% |
| Current Drawdown | -44.06% | -35.87% |
Fundamentals
| SNDX | VKTX | |
|---|---|---|
| Market Cap | $1.38B | $6.75B |
| EPS | -$3.64 | -$0.94 |
| PEG Ratio | 0.00 | -0.03 |
| Total Revenue (TTM) | $16.54M | $436.00K |
| Gross Profit (TTM) | -$28.07M | $126.00K |
| EBITDA (TTM) | -$315.71M | -$133.66M |
Correlation
The correlation between SNDX and VKTX is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNDX vs. VKTX - Performance Comparison
In the year-to-date period, SNDX achieves a -24.99% return, which is significantly lower than VKTX's 225.63% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNDX vs. VKTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Syndax Pharmaceuticals, Inc. (SNDX) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNDX vs. VKTX - Dividend Comparison
Neither SNDX nor VKTX has paid dividends to shareholders.
Drawdowns
SNDX vs. VKTX - Drawdown Comparison
The maximum SNDX drawdown since its inception was -78.98%, smaller than the maximum VKTX drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for SNDX and VKTX. For additional features, visit the drawdowns tool.
Volatility
SNDX vs. VKTX - Volatility Comparison
Syndax Pharmaceuticals, Inc. (SNDX) has a higher volatility of 31.88% compared to Viking Therapeutics, Inc. (VKTX) at 28.83%. This indicates that SNDX's price experiences larger fluctuations and is considered to be riskier than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNDX vs. VKTX - Financials Comparison
This section allows you to compare key financial metrics between Syndax Pharmaceuticals, Inc. and Viking Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities